Segment Information (Tables)

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Schedule of segment information

	Cannabis and Medical Marijuana Segment		Facilities Operations Related			Corporate, Other, and Eliminations			Consolidated
2022
Net sales	$	37,659	$	7,670,641		$	(2,585	)	$	7,705,715
Operating income (loss)		32,909		(830,098	)		(828,109	)		(1,625,298	)
Interest income		-		5			58,725			58,730
Interest expense				46,321			33,878			80,199
Total assets		1,000		3,302,931			1,689,961			4,993,892
Property additions		-		63,089			-			63,089
Fixed asset depreciation and amortization		-		69,176			2,081			71,257
2021
Net sales	$	40,764	$	5,969,674		$	-		$	6,010,438
Operating income (loss)		26,849		95,336			(526,521	)		(404,336	)
Interest income		-		3			70,226			70,229
Interest expense		-		38,330			24,062			62,392
Total assets		900,484		2,240,047			1,645,910			4,786,441
Property additions		-		160,102			1,264			161,366
Fixed asset depreciation and amortization		-		45,936			5,744			51,710

Schedule of reconciliation of revenue from segments to consolidated

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes for the years ended December 31, 2022 and 2021, as presented in the consolidated income statements:

	2022			2021
Operating loss	$	(1,625,298	)	$	(404,336	)
Employee retention tax credit (WCI)		1,350,161			-
Realized gain (loss) on investments in securities		(170,418	)		1,017
Impairment of investments		-			22,718
Interest income		58,730			70,229
Interest expense		(80,199	)		(62,392	)
Gain (loss) on equipment disposals		56,455			86
PPP loan forgiven		-			87,122
EIDL Grant		-			-
Other income		58,027			38,870
Income before income taxes	$	(352,542	)	$	(246,686	)